Pantoprazol Amarox (Pantoprazole)

Pantoprazol Amarox belongs to the proton pump inhibitor class and is indicated for conditions involving excess gastric acid secretion.

• Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis.
• Erosive gastritis and duodenal ulcer: accelerates ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid in this rare endocrine disorder.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid production, leading to a sustained decrease in gastric acidity and allowing mucosal healing.

Pantoprazol Amarox may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually transient.
• Nausea: occasional and self‑limiting.
• Abdominal pain: mild discomfort.
• Flatulence: excess gas.
• Constipation: infrequent.

Serious or Rare Side Effects

• Acute interstitial nephritis: inflammation of kidney tissue.
• Severe hypersensitivity reactions: including rash, angioedema or anaphylaxis.
• Clostridioides difficile‑associated colitis: severe diarrhea with abdominal pain.
• Osteoporotic fractures: increased risk with long‑term use.
• Low magnesium (hypomagnesemia): may cause muscle cramps or cardiac arrhythmia.
• Hepatic dysfunction: elevated liver enzymes or jaundice.

Before prescribing Pantoprazol Amarox, clinicians should evaluate patient history and potential risk factors.

• Renal impairment: adjust monitoring, as drug clearance may be reduced.
• Hepatic impairment: use with caution; monitor liver function tests.
• Long‑term therapy: assess need periodically to avoid bone density loss.
• Concomitant use of NSAIDs: increase risk of gastrointestinal bleeding.
• Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed.
• Store at below 25°C: keep in the original packaging, protect from moisture and light.

Pantoprazol Amarox can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

• Ketoconazole oral: reduced absorption due to increased gastric pH.
• Atazanavir (HIV protease inhibitor): markedly decreased plasma concentrations.
• Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely)

• Warfarin: potential alteration of INR values; monitor coagulation.
• Digoxin: possible increase in serum levels.
• Methotrexate (high‑dose): reduced renal clearance may raise toxicity.
• Phenytoin: altered metabolism may require dose adjustment.